The increasing demand for specific immunological study and therapeutic creation has spurred significant improvements in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using multiple expression platforms, including prokaryotic hosts, mammalian cell lines, and viral